Home
Login Register
> Return

Go to Forum     Add To MyCorner

Hyphens Pharma1J5

0.3 No Change

Group

Cash   

Cash

Singapore Dollar   

13-Jun 16:47

 

TRADING INFO

Open

0.3   

Buy

0.3   

High

0.3   

Low

0.3   

Previous Close

0.3   

Volume(K)

44.9   

Buy Volume(K)

19.8   

Sell Volume(K)

19.8   

 

KEY STOCK INFO

PE Ratio

NA   

Dividend Yield

-   

Price to Book Ratio

-   

Market Cap

-   

Enterprise Value

-   

52 Weeks High

0.31   

52 Weeks Low

0.26   

RSI

55.9 ( No Info )   

Williams %R

55.9 ( No Info )   

 

COMPANY INFORMATION Financial Info by

SIC

DRUGS, DRUG PROPRIETARIES, AND DRUGGISTS' SUNDRIES-WHOLESALE   

Address

16 TAI SENG STREET LEVEL 4 SINGAPORE 534138   

Phone

(65) 6338 8825   

Fax

(65)   

SIC

The company are one of Singapore?s leading specialty pharmaceutical and consumer healthcare groups leveraging on our diverse footprint in ASEAN countries.The core business comprises the following segments which is</BR>a) Specialty Pharma Principals</BR>b) Proprietary Brands</BR>c) Medical Hypermart and Digital   

AUDITOR

RSM CHIO LIM LLP   

 

FINANICALS INFORMATION All values in $millions

  
    

Financial Year

2023-12-31   

Currency

SGD   
KEY RATIOS

Operating Margin(%)

6.356   

Return on Equity Capital(%)

12.588   

Net Profit Margin(%)

5.022   

Current Ratio

1.871   

Debt to Capital at Book

0.056   
INCOME STATEMENT

EBITDA

15602.0   

EBITDA

11900.0   

Net Profit

8568.0   

Ordinary Dividend

-13790.0   
BALANCE SHEET

Intangibles

23.575   

Fixed Assets

4.864   

Long Term Investments

0.0   

Stock/Inventories

25529.0   

Cash

23369.0   

Current Liabilities

49244.0   

Long Term Debt

1979.0   

Provisions

0.0   

Minorities

0.0   

Total Shareholder Equity

65.862   
PER SHARE INFO

EBITDA per share

0.05   

EBIT per share

0.034   

Profit per share

0.028   

Book Value per share

0.137   

Financial Year

2022-12-31   

Currency

SGD   
KEY RATIOS

Operating Margin(%)

8.951   

Return on Equity Capital(%)

18.175   

Net Profit Margin(%)

6.993   

Current Ratio

2.237   

Debt to Capital at Book

0.05   
INCOME STATEMENT

EBITDA

18692.0   

EBITDA

15332.0   

Net Profit

11351.0   

Ordinary Dividend

-3427.0   
BALANCE SHEET

Intangibles

19.072   

Fixed Assets

3.017   

Long Term Investments

2.667   

Stock/Inventories

21260.0   

Cash

36480.0   

Current Liabilities

40074.0   

Long Term Debt

3229.0   

Provisions

0.0   

Minorities

0.0   

Total Shareholder Equity

70.272   
PER SHARE INFO

EBITDA per share

0.061   

EBIT per share

0.046   

Profit per share

0.037   

Book Value per share

0.166   

Financial Year

2022-12-31   

Currency

SGD   
KEY RATIOS

Operating Margin(%)

8.951   

Return on Equity Capital(%)

18.175   

Net Profit Margin(%)

6.993   

Current Ratio

2.237   

Debt to Capital at Book

0.0   
INCOME STATEMENT

EBITDA

18134.0   

EBITDA

15412.0   

Net Profit

11351.0   

Ordinary Dividend

-3427.0   
BALANCE SHEET

Intangibles

19.072   

Fixed Assets

3.017   

Long Term Investments

2.667   

Stock/Inventories

21260.0   

Cash

36480.0   

Current Liabilities

40074.0   

Long Term Debt

0.0   

Provisions

0.0   

Minorities

0.0   

Total Shareholder Equity

70.272   
PER SHARE INFO

EBITDA per share

0.059   

EBIT per share

0.046   

Profit per share

0.037   

Book Value per share

0.166   
Important: Please read our Terms and Conditions and Privacy Policy .